What question did this study set out to answer?

To evaluate the availability, accessibility, and transparency of essential regulatory and scientific documents across COVID-19 vaccine clinical trials.

August 9, 2021BMJ evidence-based medicine

Transparency of COVID-19 vaccine trials: decisions without data

View Full Paper

Ask AI

Bookmark

To evaluate the availability, accessibility, and transparency of essential regulatory and scientific documents across COVID-19 vaccine clinical trials.
Audited COVID-19 vaccine trials for the public availability of statistical analysis plans and informed consent forms.
Assessed accessibility of individual participant data and formal trial publications.
Crucial trial elements, including individual participant data and statistical protocols, frequently face restricted access or substantial release delays.
Public health recommendations and regulatory decisions often proceed without fully transparent access to underlying clinical trial data.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Methodological review reveals limited accessibility of trial protocols and data for COVID-19 vaccines, highlighting persistent transparency gaps.

Cite This Study

Tanveer et al. (2021) studied this question.

synapsesocial.com/papers/6a16b0a7202211e8406b448e https://doi.org/10.1136/bmjebm-2021-111735

View Full Paper

Ask AI

Bookmark

Implication

Methodological review reveals limited accessibility of trial protocols and data for COVID-19 vaccines, highlighting persistent transparency gaps.

Transparency of COVID-19 vaccine trials: decisions without data

Key Points

Discussion

Implication

Cite This Study

Transparency of COVID-19 vaccine trials: decisions without data

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider